statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.074
RU - Federazione Russa	247
CN - Cina	141
GB - Regno Unito	136
IE - Irlanda	135
SG - Singapore	126
BR - Brasile	76
SE - Svezia	67
UA - Ucraina	67
VN - Vietnam	50
DE - Germania	46
FR - Francia	44
HK - Hong Kong	32
IT - Italia	31
FI - Finlandia	20
IN - India	13
ZA - Sudafrica	12
KR - Corea	11
BD - Bangladesh	7
CA - Canada	7
EC - Ecuador	7
AR - Argentina	6
JP - Giappone	6
PL - Polonia	6
BE - Belgio	5
CZ - Repubblica Ceca	5
TR - Turchia	5
IQ - Iraq	4
NL - Olanda	4
PK - Pakistan	4
EG - Egitto	3
AT - Austria	2
CI - Costa d'Avorio	2
ES - Italia	2
JO - Giordania	2
KG - Kirghizistan	2
LK - Sri Lanka	2
LT - Lituania	2
LV - Lettonia	2
MA - Marocco	2
MX - Messico	2
NG - Nigeria	2
PA - Panama	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AU - Australia	1
BO - Bolivia	1
BY - Bielorussia	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
GA - Gabon	1
GE - Georgia	1
GT - Guatemala	1
HU - Ungheria	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
LA - Repubblica Popolare Democratica del Laos	1
LU - Lussemburgo	1
MU - Mauritius	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PH - Filippine	1
SA - Arabia Saudita	1
SI - Slovenia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.451

Nome	#
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network	248
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies	241
Neisseria meningitidis infection: Who, when and where?	237
Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase is based on a common pyridine nucleotide pool in the lumen of the endoplasmic reticulum	221
The glucose-6-phosphate transporter - hexose-6-phosphate dehydrogenase - 11beta-hydroxysteroid dehydrogenase type 1 system of the adipose tissue	221
Fighting Neisseria meningitidis: past and current vaccination strategies	216
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study	203
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge	197
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period	192
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus	177
Evaluating influenza vaccines: Progress and perspectives	160
Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment	151
Totale	2.464

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	52	0	0	0	0	0	0	0	0	0	17	18	17
2021/2022	176	7	27	7	19	4	6	15	13	16	14	16	32
2022/2023	203	14	22	32	26	21	44	1	15	18	1	7	2
2023/2024	177	7	4	16	8	8	45	75	1	5	3	0	5
2024/2025	332	17	15	47	15	53	22	1	19	23	15	39	66
2025/2026	757	58	98	74	161	184	25	61	27	30	39	0	0
Totale													2.464